ConductScience.org, home

Paper20178464

The role of HIF prolyl hydroxylases in tumour growth.

Jokilehto T and 1 other. J Cell Mol Med, 2010. Cited by 85 papers, by iCite.

Cite this record

ConductScience Library. The role of HIF prolyl hydroxylases in tumour growth. Papers, record 20178464. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/20178464

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
The role of HIF prolyl hydroxylases in tumour growth.
PubMed
Journal
J Cell Mol Med
PubMed
Year
2010
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't, Review
PubMed
Citations, by iCite
85
iCite
Relative citation ratio, by iCite
2.01
iCite
Revised in PubMed
2022-03-30
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Jokilehto TTerhi
2Jaakkola PMPanu M

Source PubMed

Download CSV of authors

Topics8

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Hypoxia-Inducible Factor 1Major topic
NeoplasmsMajor topic
Procollagen-Proline DioxygenaseMajor topic
Animals
Cell Hypoxia
Cell Proliferation
Humans
Oxygen

Source PubMed

Download CSV of topics

References123

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
117636018ASB4 is a hydroxylation substrate of FIH and promotes vascular differentiation via an oxygen-dependent mechanism.Mol Cell Biol2007https://conductscience.org/library/papers/17636018PubMed
213130303Targeting HIF-1 for cancer therapy.Nat Rev Cancer2003https://conductscience.org/library/papers/13130303PubMed
317440684Hypoxia in cancer: significance and impact on clinical outcome.Cancer Metastasis Rev2007https://conductscience.org/library/papers/17440684PubMed
414871811Tissue-wide expression profiling using cDNA subtraction and microarrays to identify tumor-specific genes.Cancer Res2004https://conductscience.org/library/papers/14871811PubMed
510074911Angiogenesis vs. response after combined chemoradiotherapy of squamous cell head and neck cancer.Int J Cancer1999https://conductscience.org/library/papers/10074911PubMed
615104534Hypoxia-inducible factor-1 (HIF-1) promotes its degradation by induction of HIF-alpha-prolyl-4-hydroxylases.Biochem J2004https://conductscience.org/library/papers/15104534PubMed
716509823Characterization of different isoforms of the HIF prolyl hydroxylase PHD1 generated by alternative initiation.Biochem J2006https://conductscience.org/library/papers/16509823PubMed
810353251The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis.Nature1999https://conductscience.org/library/papers/10353251PubMed
914695194Expression of prolyl-hydroxylase-1 (PHD1/EGLN2) suppresses hypoxia inducible factor-1alpha activation and inhibits tumor growth.Cancer Res2003https://conductscience.org/library/papers/14695194PubMed
1016278385
The androgen receptor is significantly associated with vascular endothelial growth factor and hypoxia sensing via hypoxia-inducible factors HIF-1a, HIF-2a, and the prolyl hydroxylases in human prostate cancer.
Clin Cancer Res2005https://conductscience.org/library/papers/16278385PubMed
1110944113Mechanism of regulation of the hypoxia-inducible factor-1 alpha by the von Hippel-Lindau tumor suppressor protein.EMBO J2000https://conductscience.org/library/papers/10944113PubMed
1218299578Interaction with factor inhibiting HIF-1 defines an additional mode of cross-coupling between the Notch and hypoxia signaling pathways.Proc Natl Acad Sci U S A2008https://conductscience.org/library/papers/18299578PubMed
1311574160Characterization and comparative analysis of the EGLN gene family.Gene2001https://conductscience.org/library/papers/11574160PubMed
1419477431Tumor vasculature is regulated by PHD2-mediated angiogenesis and bone marrow-derived cell recruitment.Cancer Cell2009https://conductscience.org/library/papers/19477431PubMed
1512778166Regulation of angiogenesis by hypoxia: role of the HIF system.Nat Med2003https://conductscience.org/library/papers/12778166PubMed
1619639506Expression of the cellular oxygen sensor PHD2 (EGLN-1) predicts radiation sensitivity in squamous cell cancer of the head and neck.Int J Radiat Biol2009https://conductscience.org/library/papers/19639506PubMed
179278421Hypoxia-inducible factor 1alpha (HIF-1alpha) protein is rapidly degraded by the ubiquitin-proteasome system under normoxic conditions. Its stabilization by hypoxia depends on redox-induced changes.J Biol Chem1997https://conductscience.org/library/papers/9278421PubMed
1818332118Abnormal sympathoadrenal development and systemic hypotension in PHD3-/- mice.Mol Cell Biol2008https://conductscience.org/library/papers/18332118PubMed
1919420289Increased prolyl 4-hydroxylase expression and differential regulation of hypoxia-inducible factors in the aged rat brain.Am J Physiol Regul Integr Comp Physiol2009https://conductscience.org/library/papers/19420289PubMed
2015652751Succinate links TCA cycle dysfunction to oncogenesis by inhibiting HIF-alpha prolyl hydroxylase.Cancer Cell2005https://conductscience.org/library/papers/15652751PubMed

See all 123 referencesDownload CSV of references

Cited by55

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 85 citations.

PMIDTitleJournalYearIn PapersSource
41543162<p>Prolyl hydroxylase domain proteins: Localization, regulation, function and their role in erythropoiesis (Review)</p>.Mol Med Rep2026https://conductscience.org/library/papers/41543162PubMed
39790223Non-canonical Function of Prolyl Hydroxylase Domain 2 in Breast Cancer Cell Growth and Progression: Role of Peptidyl-prolyl Cis-trans Isomerase NIMA-interacting 1.J Cancer Prev2024https://conductscience.org/library/papers/39790223PubMed
39201738Tricarboxylic Acid Cycle Relationships with Non-Metabolic Processes: A Short Story with DNA Repair and Its Consequences on Cancer Therapy Resistance.Int J Mol Sci2024https://conductscience.org/library/papers/39201738PubMed
39007099Prolyl hydroxylase domain enzyme PHD2 inhibits proliferation and metabolism in non-small cell lung cancer cells in HIF-dependent and HIF-independent manners.Front Oncol2024https://conductscience.org/library/papers/39007099PubMed
36976352Decreased expression of prolyl hydroxylase 1 is associated with poor prognosis in colorectal cancers.J Cancer Res Clin Oncol2023https://conductscience.org/library/papers/36976352PubMed
36532768Targeting hypoxia-inducible factors for breast cancer therapy: A narrative review.Front Pharmacol2022https://conductscience.org/library/papers/36532768PubMed
36139386Regulating the Expression of HIF-1α or lncRNA: Potential Directions for Cancer Therapy.Cells2022https://conductscience.org/library/papers/36139386PubMed
35705735The multifaceted role of EGLN family prolyl hydroxylases in cancer: going beyond HIF regulation.Oncogene2022https://conductscience.org/library/papers/35705735PubMed
35592438Prolyl Hydroxylase Domain Protein Inhibitor Not Harboring a 2-Oxoglutarate Scaffold Protects against Hypoxic Stress.ACS Pharmacol Transl Sci2022https://conductscience.org/library/papers/35592438PubMed
35159396Challenging the Paradigm: Anti-Inflammatory Interleukins and Angiogenesis.Cells2022https://conductscience.org/library/papers/35159396PubMed
34250767Identification of novel mutations and functional impacts of EPAS1 in colorectal cancer.Cancer Med2021https://conductscience.org/library/papers/34250767PubMed
34065840
Gene Expression Levels of the Prolyl Hydroxylase Domain Proteins PHD1 and PHD2 but Not PHD3 Are Decreased in Primary Tumours and Correlate with Poor Prognosis of Patients with Surgically Resected Non-Small-Cell Lung Cancer.
Cancers (Basel)2021https://conductscience.org/library/papers/34065840PubMed
34062959Role of Hypoxia in the Control of the Cell Cycle.Int J Mol Sci2021https://conductscience.org/library/papers/34062959PubMed
33436044Targeting hypoxic tumor microenvironment in pancreatic cancer.J Hematol Oncol2021https://conductscience.org/library/papers/33436044PubMed
33042797Molecular Deregulation of EPAS1 in the Pathogenesis of Esophageal Squamous Cell Carcinoma.Front Oncol2020https://conductscience.org/library/papers/33042797PubMed
32610612Targeting Altered Energy Metabolism in Colorectal Cancer: Oncogenic Reprogramming, the Central Role of the TCA Cycle and Therapeutic Opportunities.Cancers (Basel)2020https://conductscience.org/library/papers/32610612PubMed
31692952Prolyl hydroxylase-3 is a novel renal cell carcinoma biomarker.Investig Clin Urol2019https://conductscience.org/library/papers/31692952PubMed
31656668Prolyl hydroxylase 3 involvement in lung cancer progression under hypoxic conditions: association with hypoxia-inducible factor-1α and pyruvate kinase M2.J Thorac Dis2019https://conductscience.org/library/papers/31656668PubMed
30977114Clinical implications of the oncometabolite succinate in SDHx-mutation carriers.Clin Genet2020https://conductscience.org/library/papers/30977114PubMed
30931508Hypoxia as a barrier to immunotherapy in pancreatic adenocarcinoma.Clin Transl Med2019https://conductscience.org/library/papers/30931508PubMed

See all 55 cited byDownload CSV of cited by

Genes31

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
AHR196PubTator's text mininghttps://conductscience.org/library/genes/196NCBI Gene
ARNT405PubTator's text mininghttps://conductscience.org/library/genes/405NCBI Gene
ATF4468PubTator's text mininghttps://conductscience.org/library/genes/468NCBI Gene
BNIP3664PubTator's text mininghttps://conductscience.org/library/genes/664NCBI Gene
BNIP3L665PubTator's text mininghttps://conductscience.org/library/genes/665NCBI Gene
CREBBP1387PubTator's text mininghttps://conductscience.org/library/genes/1387NCBI Gene
EGLN154583PubTator's text mininghttps://conductscience.org/library/genes/54583NCBI Gene
EGLN2112398PubTator's text mininghttps://conductscience.org/library/genes/112398NCBI Gene
EGLN3112399PubTator's text mininghttps://conductscience.org/library/genes/112399NCBI Gene
EP3002033PubTator's text mininghttps://conductscience.org/library/genes/2033NCBI Gene
EPAS12034PubTator's text mininghttps://conductscience.org/library/genes/2034NCBI Gene
EPO2056PubTator's text mininghttps://conductscience.org/library/genes/2056NCBI Gene
ERBB22064PubTator's text mininghttps://conductscience.org/library/genes/2064NCBI Gene
FGF22247PubTator's text mininghttps://conductscience.org/library/genes/2247NCBI Gene
FH2271PubTator's text mininghttps://conductscience.org/library/genes/2271NCBI Gene
FKBP823770PubTator's text mininghttps://conductscience.org/library/genes/23770NCBI Gene
HIF1A3091PubTator's text mininghttps://conductscience.org/library/genes/3091NCBI Gene
HIF1AN55662PubTator's text mininghttps://conductscience.org/library/genes/55662NCBI Gene
IKBKB3551PubTator's text mininghttps://conductscience.org/library/genes/3551NCBI Gene
ING451147PubTator's text mininghttps://conductscience.org/library/genes/51147NCBI Gene

See all 31 genesDownload CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/20178464

GET https://conductscience.org/api/papers/v1/20178464/references?page=2